- Check who was studied and how many.
- Randomised, placebo-controlled, blinded designs are strongest.
- Note the exact preparation and dose.
- Read limitations and funding, not just the abstract.
The parts of a study
| Section | What to look for |
|---|---|
| Abstract | Summary; useful but incomplete |
| Methods | Participants, design, preparation, dose, outcomes |
| Results | Numbers, differences between groups, dropouts |
| Discussion | Authors’ interpretation and limitations |
| Funding and conflicts | Who paid and who supplied the product |
1. Who was studied, and how many?
Shilajit trials have often involved a few dozen participants, from specific groups such as healthy men aged 45 to 55, active men, or postmenopausal women with low bone density.[1][2][3] Results apply most directly to people like those studied. Small numbers make results less certain; see sample size.
2. How was it designed?
- RandomisedParticipants assigned by chance.
- Placebo-controlledA comparison group taking a dummy.
- BlindedParticipants and ideally researchers don’t know who takes what.
- Human, not animal or cellSee human vs animal evidence.
3. Which preparation and dose?
Several shilajit trials used the same branded, standardised extract, PrimaVie, at a few hundred milligrams a day.[1][2][3] Results for that extract can’t be assumed for a resin with different origin and processing; see why preparation and dose matter and why research on one preparation may not apply to another.
4. What was measured, and for how long?
Check whether the outcome is something people feel or need, such as strength or bone density, or a lab marker, such as a hormone level. Markers can move without any noticeable benefit. Note the duration: 8 weeks, 90 days or 48 weeks give different kinds of evidence; see what research measures.
5. Were results significant and meaningful?
Statistical significance means a result is unlikely to be due to chance alone; it doesn’t mean the effect is large or important. Look at the size of the difference between groups, and whether it would matter in practice; see statistical significance.
6. What are the limitations?
Good papers state their limitations: small samples, short duration, a single centre, a specific population. Read them. They are often the most honest part of a study and tell you how far the findings can be stretched.
7. Who funded it?
Funding and conflict-of-interest statements tell you who paid for the study and whether authors have ties to the product. Industry funding doesn’t make results wrong, but it makes independent replication more important; see who funds shilajit research.
A quick reading checklist
- Human trial?
- Randomised, placebo-controlled, blinded?
- How many participants, and who?
- Which preparation and dose?
- Meaningful outcome and duration?
- Size of effect, not just significance?
- Limitations and funding?
One study isn’t proof
Even a well-designed single trial needs replication before it can support a confident conclusion. That is why our evidence ratings take replication into account; see why one study doesn’t prove a health claim and evidence ratings.
Why abstracts can mislead
Abstracts are short summaries written by the authors, and they tend to emphasise positive findings. They rarely mention dropouts, outcomes that didn’t change, or funding. Many marketing claims are based on abstracts alone. Reading the methods and results sections, even quickly, gives a much more accurate picture.
Applying the steps to a real trial
Take the 90-day testosterone trial: healthy men aged 45 to 55, randomised, placebo-controlled, using 250 mg of a purified extract twice daily.[1] Applying the checklist shows its strengths, a controlled design, and its limits, one preparation, one age group, a hormone marker as the main outcome and no independent replication. Our full discussion is in shilajit and testosterone.
Putting it into practice
When a product cites a study, find it and run through the checklist. Note especially whether the product contains the same preparation at the same dose. You will often find the study is real but says less than the marketing suggests.
In short
A study is only as useful as its design, its population and its preparation. Reading for those details protects you from overstated claims.
Where to find studies
Most shilajit studies are indexed in PubMed, and many are free to read through PubMed Central. Searching the product name or “shilajit” with a topic, such as testosterone or bone, usually finds the key papers. Our pages link to the studies we cite in the sources section at the end of each article. Reading the original is always worth it. Always.
The bottom line
Read beyond the abstract: who was studied, the design, the exact preparation and dose, meaningful outcomes and effect sizes, limitations and funding. A single small trial can point in a direction but rarely settles a question.
Frequently asked questions
How do I read a shilajit study?
Check participants, design, preparation and dose, outcomes, effect size, limitations and funding.
What is the strongest study design?
Randomised, placebo-controlled, blinded human trials.
Why does the preparation matter?
Results for one standardised extract can’t be assumed for other products.
Is the abstract enough?
No. It omits details such as limitations and funding.
What is a surrogate outcome?
A lab marker, such as a hormone level, that may not reflect a noticeable benefit.
Does statistical significance mean a large effect?
No. It means the result is unlikely to be due to chance.
Does industry funding mean results are wrong?
No, but it makes independent replication more important.
Sources & further reading
Primary research, regulators and standards bodies are cited first. A source being listed here does not mean it supports every claim made by sellers; it supports the specific statement it is attached to.
- Pandit S, Biswas S, Jana U, De RK, Mukhopadhyay SC, Biswas TK. Clinical evaluation of purified Shilajit on testosterone levels in healthy volunteers. Andrologia 48(5):570–575, 2016. PMID 26395129. View source (opens in a new tab) [Randomised controlled trial]
- Keller JL, Housh TJ, Hill EC, Smith CM, Schmidt RJ, Johnson GO. The effects of Shilajit supplementation on fatigue-induced decreases in muscular strength and serum hydroxyproline levels. Journal of the International Society of Sports Nutrition 16:3, 2019. doi:10.1186/s12970-019-0270-2; PMID 30728074. View source (opens in a new tab) [Randomised controlled trial]
- Pingali U, Nutalapati C. Shilajit extract reduces oxidative stress, inflammation, and bone loss to dose-dependently preserve bone mineral density in postmenopausal women with osteopenia: a randomized, double-blind, placebo-controlled trial. Phytomedicine 105:154334, 2022. doi:10.1016/j.phymed.2022.154334; PMID 35933897. View source (opens in a new tab) [Randomised controlled trial]